NFKB1 and rheumatoid arthritis: As another example of inflammation-modulatory properties, Liu et al. developed a transformable peptide nanoplatform (BP-FFVLK-DSGLDSM, BFD) designed to treat rheumatoid arthritis (RA) by targeting the NF-κB/IκBα signaling pathway.